Nanomedicine-Driven Advances: Enhancing Checkpoint Inhibition and CAR-T Therapies in Cancer Immunotherapy
Cancer immunotherapy has revolutionized oncological treatment recently, offering new hope for improved survival and disease management. Among the most notable advances are immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell (CAR-T) therapies, which have shown unprecedented clinical efficacy across various malignancies [1-3].
Authors
- Irami Araújo-Filho (ORCID: https://orcid.org/0000-0003-2471-7447)
Institutions
- Universidade Potiguar (BR)
Publication Details
- Journal
- Biomedical Journal of Scientific & Technical Research
- Published
- 2024-10-17
- DOI
- https://doi.org/10.26717/bjstr.2024.59.009251
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidade Federal do Rio Grande do Norte